Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis.
Fischer K, Lellouche N, Damy T, Martins R, Clementy N, Bisson A, Lesaffre F, Espinosa M, Garcia R, Degand B, Serzian G, Jourda F, Huttin O, Guichard JB, Devilliers H, Eicher JC, Laurent G, Guenancia C.
Fischer K, et al. Among authors: eicher jc.
ESC Heart Fail. 2022 Feb;9(1):740-750. doi: 10.1002/ehf2.13663. Epub 2021 Nov 3.
ESC Heart Fail. 2022.
PMID: 34734471
Free PMC article.